FDA Underlines Disapproval Of Drug-Supplement Combos In Letter To P&G

02 Nov 2009

• By The Tan Sheet

FDA notes once again that combination OTC drug and dietary supplement products are unapproved new drugs with a warning letter sent Oct. 29 to Procter & Gamble about Vicks DayQuil Plus Vitamin C and VicksNyQuil Plus Vitamin C

FDA Underlines Disapproval Of Drug-Supplement Combos In Letter To P&G

More from Archive

More from Pink Sheet